These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 29538157)

  • 1. Resynchronization therapy in heart failure: the 'nonresponder'.
    Sinagra G; Proclemer A; Zecchin M
    J Cardiovasc Med (Hagerstown); 2018 Feb; 19 Suppl 1():e112-e115. PubMed ID: 29538157
    [No Abstract]   [Full Text] [Related]  

  • 2. Cardiac resynchronization therapy: a decade of experience and the dilemma of nonresponders.
    Ganjehei L; Razavi M; Massumi A
    Tex Heart Inst J; 2011; 38(4):358-60. PubMed ID: 21841860
    [No Abstract]   [Full Text] [Related]  

  • 3. Cardiac resynchronization: what's next?
    Leclercq C
    Arch Cardiovasc Dis; 2012; 105(6-7):335-7. PubMed ID: 22800717
    [No Abstract]   [Full Text] [Related]  

  • 4. An individualized left ventricular lead-targeting strategy improves long-term survival of cardiac resynchronization therapy patients and influences the benefit of the implantable cardioverter-defibrillator: a long-term follow-up of the TARGET study.
    Barra S; Yu E; Khan F; Dutka D; Virdee M
    J Cardiovasc Med (Hagerstown); 2017 Jul; 18(7):553-555. PubMed ID: 27136703
    [No Abstract]   [Full Text] [Related]  

  • 5. Biventricular pacing in normal hearts.
    Bhat T; Teli S; Lafferty J; Bekieth S; Kowalski M; Bhat H
    Rev Cardiovasc Med; 2012; 13(2-3):e53-61. PubMed ID: 23160162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contractibility sensor signal evolution predicts cardiovascular events in patients with cardiac resynchronization therapy.
    Garcia R; Guenancia C; Le Gal F; Rehman M; Tao V; Christiaens L; Ingrand P; Degand B
    Arch Cardiovasc Dis; 2019 Jan; 112(1):22-30. PubMed ID: 30591324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors and the effect of cardiac resynchronization therapy on cardiac and non-cardiac mortality in MADIT-CRT.
    Perkiomaki JS; Ruwald AC; Kutyifa V; Ruwald MH; Mcnitt S; Polonsky B; Goldstein RE; Haigney MC; Krone RJ; Zareba W; Moss AJ;
    Europace; 2015 Dec; 17(12):1816-22. PubMed ID: 26071234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac Resynchronization Therapy: How to Decrease Nonresponders.
    Tolosana JM; Mont L
    Heart Fail Clin; 2017 Jan; 13(1):233-240. PubMed ID: 27886928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-Term Outcomes With Cardiac Resynchronization Therapy in Patients With Mild Heart Failure With Moderate Renal Dysfunction.
    Daimee UA; Moss AJ; Biton Y; Solomon SD; Klein HU; McNitt S; Polonsky B; Zareba W; Goldenberg I; Kutyifa V
    Circ Heart Fail; 2015 Jul; 8(4):725-32. PubMed ID: 26038537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac resynchronization therapy in patients with end-stage hypertrophic cardiomyopathy.
    Killu AM; Park JY; Sara JD; Hodge DO; Gersh BJ; Nishimura RA; Asirvatham SJ; McLeod CJ
    Europace; 2018 Jan; 20(1):82-88. PubMed ID: 29315424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between right ventricular lead position and clinical outcomes in patients with cardiac resynchronization therapy.
    Kronborg MB; Johansen JB; Riahi S; Petersen HH; Haarbo J; Jørgensen OD; Nielsen JC
    Europace; 2018 Apr; 20(4):629-635. PubMed ID: 28340014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative Effectiveness of Cardiac Resynchronization Therapy Among Patients With Heart Failure and Atrial Fibrillation: Findings From the National Cardiovascular Data Registry's Implantable Cardioverter-Defibrillator Registry.
    Khazanie P; Greiner MA; Al-Khatib SM; Piccini JP; Turakhia MP; Varosy PD; Masoudi FA; Curtis LH; Hernandez AF;
    Circ Heart Fail; 2016 Jun; 9(6):. PubMed ID: 27296396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical outcomes in cardiac resynchronization therapy-defibrillator recipients 80 years of age and older.
    Adelstein EC; Liu J; Jain S; Schwartzman D; Althouse AD; Wang NC; Gorcsan J; Saba S
    Europace; 2016 Mar; 18(3):420-7. PubMed ID: 26487669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. QRS axis and the benefit of cardiac resynchronization therapy in patients with mildly symptomatic heart failure enrolled in MADIT-CRT.
    Brenyo A; Rao M; Barsheshet A; Cannom D; Quesada A; McNitt S; Huang DT; Moss AJ; Zareba W
    J Cardiovasc Electrophysiol; 2013 Apr; 24(4):442-8. PubMed ID: 23252875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atrial fibrillation in cardiac resynchronization therapy with a defibrillator: a risk factor for mortality, appropriate and inappropriate shocks.
    van Boven N; Theuns D; Bogaard K; Ruiter J; Kimman G; Berman L; VAN DER Ploeg T; Kardys I; Umans V
    J Cardiovasc Electrophysiol; 2013 Oct; 24(10):1116-22. PubMed ID: 23889733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence, predictors, and procedural results of upgrade to resynchronization therapy: the RAFT upgrade substudy.
    Essebag V; Joza J; Birnie DH; Sapp JL; Sterns LD; Philippon F; Yee R; Crystal E; Kus T; Rinne C; Healey JS; Sami M; Thibault B; Exner DV; Coutu B; Simpson CS; Wulffhart Z; Yetisir E; Wells G; Tang AS
    Circ Arrhythm Electrophysiol; 2015 Feb; 8(1):152-8. PubMed ID: 25417892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complete left bundle branch block and smaller left atrium are predictors of response to cardiac resynchronization therapy in advanced heart failure.
    Imamura T; Kinugawa K; Nitta D; Komuro I
    Circ J; 2015; 79(11):2414-21. PubMed ID: 26376671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes of contemporary mechanical circulatory support device configurations in patients with severe biventricular failure.
    Levin AP; Jaramillo N; Garan AR; Takeda K; Takayama H; Yuzefpolskaya M; Mancini DM; Naka Y; Colombo PC; Topkara VK
    J Thorac Cardiovasc Surg; 2016 Feb; 151(2):530-5.e2. PubMed ID: 26651960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional response to cardiac resynchronization therapy is associated with improved clinical outcome and absence of appropriate shocks.
    Van Boven N; Bogaard K; Ruiter J; Kimman G; Theuns D; Kardys I; Umans V
    J Cardiovasc Electrophysiol; 2013 Mar; 24(3):316-22. PubMed ID: 23210664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sex Differences in Long-Term Outcomes With Cardiac Resynchronization Therapy in Mild Heart Failure Patients With Left Bundle Branch Block.
    Biton Y; Zareba W; Goldenberg I; Klein H; McNitt S; Polonsky B; Moss AJ; Kutyifa V;
    J Am Heart Assoc; 2015 Jun; 4(7):. PubMed ID: 26124205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.